No phaseRecruitingAge-related condition
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
Effects of Cerebellar Transcranial Magnetic Stimulation on Patients With Alzheimer's Disease：A Multicenter Randomized Controlled Trial
- Sponsor
- Xijing Hospital (Academic or other)
- Enrolment
- 100 planned
- Conditions
- Alzheimer Disease; Transcranial Magnetic Stimulation; Cerebellum
- Interventions
- Intermittent Theta-Burst Transcranial Magnetic Stimulation
- Ages
- adults, older adults
- Registry
- NCT06669182
Full record on ClinicalTrials.gov
From the registry
Alzheimer's Disease (AD) is the primary cause of dementia, with its prominent feature being cognitive decline. The cerebellum plays a crucial role in cognitive processing, making it a potential target for therapeutic intervention. This study will be conducted to evaluate the efficacy and safety of cerebellar Intermittent theta-burst stimulation (CRB-iTBS) in participants with mild Alzheimer's disease on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 3 months of treatment in the Core Study. This project aims to provide a valid treatment to improve the cognitive function and quality of life for those with Alzheimer's disease.
Primary outcomes
- The changes in CDR-SB（Clinical Dementia Rating-Sum of Boxes）
History
Study completion
Primary completion
Last registry update
Started
Registered